Connection

Thomas Agoritsas to Betacoronavirus

Back to Details
This is a "connection" page, showing publications Thomas Agoritsas has written about Betacoronavirus.
Thomas Agoritsas
Connection Strength
0.052
Betacoronavirus
  1. A living WHO guideline on drugs for covid-19. BMJ. 2020 09 04; 370:m3379.
    View in: PubMed
    Score: 0.010
  2. Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test. Eur J Clin Invest. 2020 Oct; 50(10):e13357.
    View in: PubMed
    Score: 0.010
  3. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020 07 30; 370:m2980.
    View in: PubMed
    Score: 0.009
  4. Remdesivir for severe covid-19: a clinical practice guideline. BMJ. 2020 07 30; 370:m2924.
    View in: PubMed
    Score: 0.009
  5. Validation of a commercially available SARS-CoV-2 serological immunoassay. Clin Microbiol Infect. 2020 Oct; 26(10):1386-1394.
    View in: PubMed
    Score: 0.009
  6. Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial. BMJ Open. 2020 11 12; 10(11):e040110.
    View in: PubMed
    Score: 0.002
  7. A Mobile Health Platform to Disseminate Validated Institutional Measurements During the COVID-19 Outbreak: Utilization-Focused Evaluation Study. JMIR Public Health Surveill. 2020 04 14; 6(2):e18668.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.